-
Novartis and Bayer seek to oppose High Court ruling over NHS decision to use cheaper drug
pharmafile
October 19, 2018
Swiss multinational Novartis have joined German pharma firm Bayer in appealing a High Court ruling over 12 NHS clinical commissioning groups (CCGs) decision to use a cheaper...
-
Bayer plea for stay on compulsory license dismissed
biospectrumasia
October 12, 2018
Bayer plea for stay on compulsory license dismissed
-
Celebrating sales and marketing excellence
pharmatimes
October 11, 2018
Such is the link between the two disciplines, Marketer of the Year will celebrate its 25th anniversary at The Tower Hotel, London on Thursday 15 November, alongside the all-new Sales Awards.
-
Bayer taps veteran Sebastian Guth to lead American pharma as Carsten Brunn flees to biotech
fiercepharma
September 29, 2018
Bayer's Sebastian Guth will take on his new role on Dec. 1. (Bayer)
-
Bayer taps veteran Sebastian Guth to lead American pharma as Carsten Brunn flees to biotech
fiercepharma
September 28, 2018
Bayer’s pharma leader in the Americas is heading off to biotech, but the German drugmaker has a seasoned veteran ready to step up.
-
Bayer Appoints Lead for Pharmaceuticals Business in the Americas
americanpharmaceuticalreview
September 28, 2018
Bayer announced the appointment of Sebastian Guth as President of Pharmaceuticals, Americas Region, comprising the United States, Canada, Central and Latin America, effective December 1, 2018.
-
High Court rejects Novartis, Bayer’s bid to outlaw off-label Avastin
pharmatimes
September 27, 2018
Bayer and Novartis have lost a landmark case in the UK seeking to prevent the off-label use of Roche’s Avastin to treat wet AMD...
-
English court backs NHS in fight with Bayer, Novartis over off-label Avastin use
fiercepharma
September 25, 2018
After a long legal fight with Bayer and Novartis, England’s National Health Service has won the right to use a compounded form of Roche’s Avastin off-label in patients with wet age-related macular degeneration over much ...
-
Bayer says Monsanto India integration to complete in one year
expressbpd
September 25, 2018
Bayer completed the deal to acquire US-based Monsanto recently and the acquisition of Monsanto has been completed globally but it is still in process in India
-
Bayer wins US nod for Jivi
pharmatimes
September 14, 2018
US regulators have approved Bayer’s Jivi (formerly BAY94-9027), a longer-acting Factor VIII therapy designed to reduce the number of infusions...